Using the Administration to Update and Evaluate Urban Planning for Cities

The planning process takes place to face a number of challenges and obstacles that address and continue for a long time to form a plan that includes the fundamental changes in society and keep pace with population and urban growth, and planning and the formation of blueprints is a basis to meet the needs of society, but the passage of time to configure it to keep pace with growth and the speed of increasing population and technical growth, it requires research studies Faster to configure a re-planning of plans and studies as an alternative to re-planning and supporting them with follow-up and continuous evaluation processes that are among the basic components of management operations, which is the solution to reduce problems and shortcomings and support for planning processes as a current and long-term treatment The role of management is important to support the planning process in the presence of evaluation and follow-up to meet the requirements of the city and its expansion Urban development and development, and looking forward to the most prominent concepts and ways that decision-makers take with techniques and methods that make the city and the services provided to it in the best image that makes the city with urban development and urban management represented by the countries.

Download Full-text

Pituitary apoplexy in acromegaly during bromocriptine therapy

Acta Endocrinologica ◽

10.1530/acta.0.0980171 ◽

1981 ◽

Vol 98 (2) ◽

pp. 171-177 ◽

Cited By ~ 32

Author(s):

Tohru Yamaji ◽

Miyuki Ishibashi ◽

Kinori Kosaka ◽

Takanori Fukushima ◽

Tomokatsu Hori ◽

...

Keyword(s):

Growth Hormone ◽

Pituitary Adenoma ◽

Pituitary Apoplexy ◽

Term Treatment ◽

Serum Growth Hormone ◽

Long Term Treatment ◽

Active Acromegaly

Abstract. Two cases of pituitary apoplexy occurring in the course of long-term bromocriptine therapy for active acromegaly are described. Although bromocriptine was effective in lowering serum growth hormone levels and concomitant clinical improvement was achieved, both patients developed an acute episode suggesting pituitary apoplexy when the therapy was continued for 6 and 24 months, respectively. Surgery verified marked haemorrhage and necrosis of an eosinophilic pituitary adenoma in each case. Bromocriptine may have suppressed the growth of these pituitary adenomas resulting in necrosis of the tumour, followed by haemorrhage into the adenoma. Pituitary apoplexy has not been documented as a complication of bromocriptine therapy. This report points out a possible role of bromocriptine in the development of this catastrophe and that careful follow-up is required when long-term treatment with bromocriptine is attempted.

Download Full-text

Long-Term Treatment Outcomes for Heroin Dependence: The 11-Year Follow-Up of the ATOS Study

PsycEXTRA Dataset ◽

10.1037/e612192013-001 ◽

2013 ◽

Author(s):

Christina Marel ◽

Maree Teesson ◽

Shane Darke ◽

Katherine Mills ◽

Joanne Ross ◽

...

Keyword(s):

Treatment Outcomes ◽

Term Treatment ◽

Heroin Dependence ◽

Long Term Treatment

Download Full-text

Faculty Opinions recommendation of Long-term treatment follow-up of children with sickle cell disease monitored with abnormal transcranial Doppler velocities.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726126988.793518505 ◽

2016 ◽

Author(s):

Adlette Inati ◽

Hussein Abbas

Keyword(s):

Sickle Cell Disease ◽

Sickle Cell ◽

Transcranial Doppler ◽

Term Treatment ◽

Cell Disease ◽

Long Term Treatment

Download Full-text

Cognitive Treatment for OCD

10.1093/oxfordhb/9780195376210.013.0076 ◽

2012 ◽

Author(s):

Maureen L. Whittal ◽

Melisa Robichaud

Keyword(s):

Term Treatment ◽

Future Directions ◽

Cognitive Treatment ◽

Long Term Treatment ◽

Inflated Responsibility ◽

And Control ◽

The Relationship ◽

Control Of Thoughts

The cornerstone of cognitive treatment (CT) for OCD is based upon the knowledge that unwanted intrusions are essentially a universal experience. As such, it is not the presence of the intrusion that is problematic but rather the associated meaning or interpretation. Treatment is flexible, depending upon the nature of the appraisals and beliefs, but can include strategies focused on inflated responsibility and overestimation of threat, importance and control of thoughts, and the need for perfectionism and certainty. The role of concealment and the relationship to personal values are important maintaining and etiological factors. The short-term and long-term treatment outcome is reviewed, along with predictors of treatment response and mechanisms of action, and the chapter concludes with future directions regarding CT for OCD.

Download Full-text

Defining the role of SGAs in the long-term treatment of bipolar disorder

Bipolar Disorders ◽

10.1111/bdi.12472 ◽

2017 ◽

Vol 19 (1) ◽

pp. 65-67 ◽

Cited By ~ 4

Author(s):

Gin S Malhi ◽

Grace Morris ◽

Amber Hamilton ◽

Tim Outhred ◽

Pritha Das

Keyword(s):

Bipolar Disorder ◽

Term Treatment ◽

Long Term Treatment

Download Full-text

The changes of corneal biomechanical properties with long-term treatment of prostaglandin analogue measured by Corvis ST

10.21203/rs.3.rs-22280/v3 ◽

2020 ◽

Author(s):

Na Wu ◽

Yuhong Chen ◽

Yaping Yang ◽

Xinghuai Sun

Keyword(s):

Open Angle Glaucoma ◽

Corneal Thickness ◽

Biomechanical Properties ◽

Term Treatment ◽

Prostaglandin Analogue ◽

Corvis St ◽

Long Term Treatment ◽

Corneal Biomechanical Properties

Abstract Background: To investigate the corneal biomechanical changes in primary open angle glaucoma (POAG) patients treated with long-term prostaglandin analogue (PGA). Methods: 111 newly diagnosed POAG patients, including 43 high tension glaucoma (HTG) and 68 normal tension glaucoma (NTG), were measured by Corvis ST to obtain intraocular pressure (IOP), central corneal thickness (CCT) and corneal biomechanical parameters at baseline and at each follow-up visit after initiation of PGA treatment. The follow-up measurements were analyzed by the generalized estimate equation model with an exchangeable correlation structure. Restricted cubic spline was employed to estimate the dose-response relation between follow-up time and corneal biomechanics．Results: The mean follow-up time was 10.3 ± 7.02 months. Deformation amplitude (β=-0.0015, P=0.016), the first applanation velocity (AV1, β=-0.0004, P=0.00058) decreased and the first applanation time (AT1, β=0.0089, P<0.000001) increased statistically significantly with PGA therapy over time after adjusting for age, gender, axial length, corneal curvature, IOP and CCT. In addition, AT1 was lower (7.2950 ± 0.2707 in NTG and 7.5889 ± 0.2873 in HTG, P=0.00011) and AV1 was greater (0.1478 ± 0.0187 in NTG and 0.1314 ± 0.0191 in HTG, P=0.00002) in NTG than in HTG after adjusting for confounding factors.Conclusions: Chronic use of PGA probably influences the corneal biomechanical properties directly, which is to make cornea less deformable. Besides, corneas in NTG tended to be more deformable compared to those in HTG with long-term treatment of PGA.

Download Full-text

The relevance of prescribing triple neurohormonal blockade in real clinical practice: the role of mineralocorticoid receptor antagonists

Consilium Medicum ◽

10.26442/20751753.2021.6.200889 ◽

2021 ◽

Vol 23 (6) ◽

pp. 491-497

Author(s):

Igor V. Zhirov ◽

◽

Igor V. Zhirov ◽

Keyword(s):

Myocardial Infarction ◽

Heart Failure ◽

Mineralocorticoid Receptor ◽

Systolic Dysfunction ◽

Term Treatment ◽

Mineralocorticoid Receptor Antagonists ◽

Long Term Treatment ◽

Real Clinical Practice

In the article is outlined the main concepts use of the mineralocorticoids receptors antagonists in the treatment of congestive heart failure and systolic dysfunction after acute myocardial infarction. Claimed the pivotal role of eplerenone in the long-term treatment strategy due to decrease of mortality and improving the clinical outcomes.

Download Full-text

Long term dual antiplatelet therapy after myocardial infarction: retrospective analysis in an outpatient population

Monaldi Archives for Chest Disease ◽

10.4081/monaldi.2021.1881 ◽

2021 ◽

Author(s):

Gennaro Ratti ◽

Antonio Maglione ◽

Emilia Biglietto ◽

Cinzia Monda ◽

Ciro Elettrico ◽

...

Keyword(s):

Myocardial Infarction ◽

Term Treatment ◽

Multivessel Disease ◽

Coronary Syndrome ◽

Anticoagulant Drugs ◽

Long Term Treatment ◽

Risk Condition ◽

History Of

Long term treatment with ticagrelor 60 mg and low-dose aspirin are indicated after acute coronary syndrome (ACS). We retrospectively reviewed aggregate data of 187 patients (155 M and 38 F) (mean age 63.8±9 years) in follow up after ACS with at least one high risk condition (Multivessel disease, diabetes, GFR<60 mL/min, history of prior myocardial infarction, age >65 years) treated with ticagrelor 60 mg twice daily (after 90 mg twice daily for 12 months). The results were compared with findings (characteristics of the patients at baseline, outcomes, bleeding) of PEGASUS-TIMI 54 trial and Eu Label. The highrisk groups were represented as follows: multivessel disease 105 pts (82%), diabetes 63 pts (33%), GFR< 60 mL/min 27 pts (14%), history of prior MI 33 pts (17%), >65 year aged 85 pts (45%). Treatment was withdrawn in 7 patients: 3 cases showed atrial fibrillation and were placed on oral anticoagulant drugs, one developed intracranial bleeding, in three patients a temporary withdrawal was due to surgery (1 colon polyposis and 2 cases of bladder papilloma). Chest pain without myocardial infarction occurred in 16 patients (revascularization was required in 9 patients). Dyspnea was present in 15 patients, but was not a cause for discontinuation of therapy. Long term treatment with ticagrelor 60 mg twice daily plus aspirin 100 mg/day showed a favourable benefit/risk profile after ACS. In this study all patients had been given ticagrelor 90 mg twice daily for 12 months and the 60 mg twice daily dosage was started immediately thereafter, unlike PEGASUS-TIMI 54 trial in which it was prescribed within a period ranging from 1 day to 1 year after discontinuation of the 90 mg dose. This makes our results more consistent with current clinical practice. However, a careful outpatient follow-up and constant counseling are mandatory to check out compliance to therapy and adverse side effects.

Download Full-text